艾博抗Abcam 特非那定，钾离子通道阻滞剂，H1受体拮抗剂

分子量471.7 Da，纯度>98%。钾离子通道阻滞剂(Kv11.1)。阻断ATP敏感性钾离子通道(IC50 = 1.2μM)。H1受体拮抗剂。

• 货号：ab120270
• 中文名称：特非那定，钾离子通道阻滞剂，H1受体拮抗剂。
• 英文名称：Terfenadine, K+ channel blocker. H1 antagonist.
• 规格：100mg
• 品牌：艾博抗Abcam
• 产地：美国/英国/中国杭州
• 货期：热销品现货，其他请咨询
• 资质：Abcam一级代理商
• 中文别名：1,8-桉油素2-外切单加氧酶，1B07_HUMAN，3多巴胺受体，5-HT2B受体，5-HT(2B)，5-HT2受体，5-羟色胺2C受体，5-羟色胺（血清素）受体2B，5-羟色胺（血清素）受体2B G蛋白偶联受体，5-羟色胺（血清素）受体6 G蛋白偶联受体，5-羟色胺2B受体，5-羟色胺6受体，5-HT-1C，5-HT-2，5-HT-6，5-HTR2C，5-HT-1C受体，5-羟色胺（血清素）受体2A，G蛋白偶联受体，5-羟色胺（血清素）受体2C，G蛋白偶联受体5-羟色胺2A受体、5-羟色胺受体1C、5-羟色胺受体2A、5-羟色胺受体2B、5-羟色胺受体2C、5-羟色胺受体6、5HT2A_HUMAN、5HT2B_HUMAN、5HT2C_HUMAN、5HT2F、5HT6R_HUMAN、A830040C14Rik、ABC成员16、MDR/TAP亚家族、ABC16、ABCB1、ABCBB_HUMAN、ADA1A_HUMAN、ADA1B_HUMAN、ADA1D_HUMAN、ADRA 1、ADRA1A、ADRA1L1、AI838772、AIS、ALPHA1AAR、AM4 7、ANDR_HUMAN、APOPAIN、AR、AR8、ARO、ARO1、AS ATP结合盒亚家族B（MDR/TAP）成员11，ATP结合盒亚家族B成员11，AW493413，Adra1c，Adra1d，*能α1A受体，*能α1B受体，*能α1C受体，*能α1D受体，*能受体α1a，*能受体α1b，*能受体α1c，*能α1A受体变体1，*能α1A受体变体11，*能α1A受体变体3，*能α1A受体变体5，*能α1A受体变体8，*受体α1A，*受体α1B阿苯达唑单加氧酶、阿苯达唑亚砜酶、α1*能受体、α1*能受体1b、α1*能受体1d、α1A*能受体、α1A*受体、α1A*受体、α1B*能受体、α1B*受体、α1B*受体、α1C*能受体、α1D*能受体、α1D*受体、α1D*受体、α1*能受体1a、α1*能受体1c、α1BAR、雄激素核受体变体2、雄激素受体、雄激素受体（二氢睾酮受体，睾丸女性化，脊髓延髓肌萎缩症，肯尼迪病）、凋亡蛋白酶Mch-3、花生四烯酸环氧酶、芳香化酶、B-4901、B-7α链、BPHS、小鼠、同源物、BRIC2、β-干扰素、胆汁酸输出泵、Bsep、CC CKR-5、CC趋化因子受体5型、CC基序趋化因子受体5 A159A、C-mpl配体、CAC1C_HUMAN、CAC1D_HUMAN、CAC1S_HUMAN、CACH 2、CACH1、CACH3、CACN 2、CACN1、CACN4、CACNA 1D、CACNL1A1、CACNL1A2、CACNL1A3、CAR、CARβ、CARA、CASP3_HUMAN、CASP7_HUMAN、CC趋化因子受体5、CC3、CCHL1A1、CCHL1A2、CCHL1A3、CCR5趋化因子（CC基序）受体5、CCR5_HUMAN、CD 195、CD195抗原、CDCD2、CHEMR13、CKR 5、CMD1E、CMH-1、CMKBR 5、CMPD2、CP19A_HUMAN、CP2J2_HUMAN、CP33、CP34、CP3A4_HUMAN、CPJ2、CPP-32、CPP32B、CPV1、CYAR、CYP19、CYP3、CYP3A、CYP3A3、CYP3A4、CYPIIIA3、CYPIIIA4、CYPIIJ2、CYPXIX、CaV1.2、Cach1b、钙通道、心肌钙通道L型α1多肽亚型1、心肌钙通道L型α1多肽亚型2钙通道心脏二氢吡啶敏感α1亚基，钙通道神经内分泌/脑型α1亚基，钙通道电压依赖性L型α1亚基，钙通道电压依赖性L型α1C亚基，钙通道电压依赖性L型α1D亚基，钙通道，L型，α1多肽，异构体3，骨骼肌，钙通道，L型，α1多肽，异构体3，骨骼肌，钙通道，L型，α1多肽，异构体3，骨骼肌，低钾性周期性麻痹，钙通道，骨骼肌二氢吡啶敏感α1亚基，钙通道，电压依赖性，L型，α1S亚基，钙通道，电压依赖性，L型，α1S亚基，b，Car 1，心脏*不敏感电压依赖性*通道α亚基、Casp3a、Caspase 3、凋亡相关半胱氨酸肽酶、Caspase 3、凋亡相关半胱氨酸蛋白酶、Caspase 3、凋亡相关半胱氨酸蛋白酶a、Caspase 7、Caspase 7凋亡相关半胱氨酸肽酶、Caspase-3、Caspase-3亚基p12、Caspase-7亚基p11、Cav1.1、Cav1.3、趋化因子CC基序受体5、趋化因子受体CCR5、类视黄酸反应组成型激活因子、组成型活性反应、组成型雄烷受体、Cyp19a1、半胱氨酸蛋白酶CPP32、细胞色素P-450AROM、细胞色素P450 19A1、细胞色素P450 2J2细胞色素P450 3A3、细胞色素P450 3A4、细胞色素P450 HLp、细胞色素P450 NF-25、细胞色素P450家族2亚家族J多肽2、细胞色素P450家族3亚家族A多肽4、细胞色素P450亚家族IIIA多肽4、细胞色素P450亚家族IIJ（花生四烯酸环氧合酶）多肽2、细胞色素P450亚家族IIJ多肽2、细胞色素P450家族19亚家族A多肽1、细胞色素P450亚家族XIX（雄激素芳构化）、细胞色素P450-PCN1、D(1A)多巴胺受体、D(2)多巴胺受体、D(3)多巴胺受体、D1A多巴胺受体、D2多巴胺受体、D2DR、D2R、DA转运蛋白、DADR、DAT、DAT 1、DHPRα1、DHPRα1亚基、DHTR、DNA复制抑制剂、DRD 1A、DRD1_HUMAN、DRD2_HUMAN、DRD3_HUMAN、二氢睾酮受体、二氢吡啶受体、二氢吡啶敏感的L型钙通道α1亚基、二氢睾酮受体(DHTR)、多巴胺D1受体、多巴胺D2受体、多巴胺D3受体、多巴胺受体D2、多巴胺受体D3、多巴胺转运蛋白、多巴胺转运蛋白1、EC 3.4.22.56、ERR a、ERR-α、ERR1蛋白、ERR1_HUMAN、ESRL 1、ESRR A、ETM1、Eag相关蛋白1、雌激素受体相关蛋白1、雌激素受体样蛋白1、雌激素合成酶、雌激素合成酶、雌激素相关受体α、雌激素、醚-a-go-go相关钾通道蛋白、醚-a-go-go相关基因钾通道1、醚-a-go-go相关蛋白1、FET1、FK506结合蛋白12雷帕霉素相关蛋白1、FK506结合蛋白12雷帕霉素相关蛋白2、FK506结合蛋白12-雷帕霉素复合物相关蛋白1、FKBP雷帕霉素相关蛋白、FKBP12-雷帕霉素复合物相关蛋白、FKBP12-雷帕霉素复合物相关蛋白1、FLJ11090、FLJ44809、FLJ78003、FRAP、FRAP1、FRAP2、成纤维细胞干扰素、G蛋白偶联受体、GEMI_HUMAN、GMNN、Geminin、Geminin DNA复制抑制剂、糖皮质激素诱导P450、H-ERG、H1R、HB1、HB2、HBBD、HC I类抗原SHCHA、HH1、HH1R、HIV-1融合辅助受体、HLA I类组织相容性抗原、HLA I类组织相容性抗原、Bα链、HLA-B组织相容性类型、HLP、HOKPP、HRH1_HUMAN、HTR2、HTR2A、HTR6、HTR2（原名HTR2C）、HUMARA、HYSP1、HisH1、组胺H(1)受体、组胺H1受体、组胺受体H1、组胺受体亚类H1、Htr2b、Htr1c、低磷酸血症性周期性麻痹症（HypoPP）、ICCD、ICE-LAP3、ICE样凋亡蛋白酶3、ICE3、IDDM22、IFB、IFF、IFN-β、IFNB 1、IFNB_HUMAN、IVF、干扰素β、干扰素β1成纤维细胞、干扰素β前体、KCNH2_HUMAN、KD、肯尼迪病(KD)、Kv11.1、L型、LICE、LICE2、LQT 2、LQT3、LQT8、MB67、MCH3、MGC104252、MGC104309、MGC11*2、MGC126680、MGC163194、MGC96956、MGC97144、MGDF、MHC I类HLA重链、MHC HLA-B细胞表面糖蛋白、MHC HLA-B跨膜糖蛋白、MHC I类抗原、MHC I类抗原HLA-Bα链、MHC I类抗原HLA-B重链、MHC I类分子、MHC I类抗原B*7、MHS5、MIP-1α受体、MKCSF、MPL配体、MPLLG、MTOR_HUMAN、恶性高热易感性5、哺乳动物雷帕霉素靶蛋白、雷帕霉素机制靶蛋白、巨核细胞集落刺激因子、巨核细胞生长发育因子、巨核细胞刺激因子、微粒体单加氧酶、骨髓增生性白血病病毒癌基因配体、NF25、NK-2受体、NK2R_HUMAN、NKNAR、NP75蛋白、NR1I3_HUMAN、NR3B1、NR3C4、神经激肽2受体、神经激肽A受体、神经递质转运蛋白、硝苯地平氧化酶、去甲*转运蛋白、核受体亚家族1组I成员3、核受体亚家族3组B成员1、核受体亚家族3 C组成员4，核受体亚家族3 C组成员4 (NR3C4)，OTTHUMP00000001983，OTTHUMP00000010550，OTTHUMP00000039393，OTTHUMP00000162543，OTTHUMP00000165052，OTTHUMP00000165053，OTTHUMP00000165054，OTTHUMP00000198350，孤儿核受体MB67，孤儿核受体NR1I3，P450AROM，P450 III类固醇诱导型，P450 PCN1，P450 III家族，P450C3，PARP裂解蛋白酶，PASNA，PFHB1，PFIC 2，PGY4 PKDYS、钾通道HERG、钾电压门控通道亚家族H（EAG相关）成员2、钾电压门控通道亚家族H成员2、血小板生成素原、前体caspase3、Yama蛋白、奎宁3-单加氧酶、RAFT1、RAPT1、ROB1、RP24-311F12.2、RP3 369A17.3、雷帕霉素和FKBP12靶蛋白1、雷帕霉素相关蛋白FRAP2、雷帕霉素靶蛋白、雷帕霉素靶蛋白1、SANDD、SBMA、SC6A2_HUMAN、SC6A3_HUMAN、SCA-1、SCAN1、SCN5A_HUMAN、5-羟色胺5HT2B受体、SKR、SLC6A3、SLC6A5、SMAX1、SPDA1、SQT1 SREBP裂解活性1、SSS1、Scn5a（基因名称）、丝氨酸/苏氨酸蛋白激酶mTOR、5-羟色胺5-HT-2C受体、5-羟色胺受体2A、5-羟色胺受体2B、5-羟色胺受体2C、5-羟色胺受体6、七次跨膜螺旋受体、P-糖蛋白姐妹蛋白、Slc6a2、*通道蛋白心肌α亚基、*通道蛋白心肌α亚基、*通道蛋白5型α亚基、*通道蛋白V型α亚基、*通道蛋白V型α亚基、*依赖性多巴胺转运体、*依赖性去甲*转运体、溶质载体家族6（神经递质转运体多巴胺）成员3、溶质载体家族6（神经递质转运体去甲*）成员5、溶质载体家族6（神经递质转运蛋白）成员3，溶质载体家族6（神经递质转运蛋白，去甲*）成员2，溶质载体家族6成员2，溶质载体家族6成员3，溶质载体家族6成员5，Spgp，脊髓延髓肌萎缩症，脊髓延髓肌萎缩症(SBMA)，类固醇激素受体ERR1，胃底血清素受体，K物质受体，TAC 2R，TAC R2，TACR 2，TACR2，TFM，THCYT1，THPO，TPO_HUMAN，TS，TTPP1，TYDP，TYDP1_HUMAN，速激肽受体2，速激肽受体2（K物质受体，神经激肽2受体），牛磺鹅脱氧胆酸6-α-羟化酶，睾丸女性化(TFM)血小板生成素、血小板生成素NIR变体1、酪氨酰-DNA磷酸二酯酶1、酪氨酰-DNA磷酸二酯酶1、VF1、可变数目串联重复序列(VNTR)、电压依赖性L型钙通道α1C亚基、电压门控L型钙通道Cav1.2α1亚基、剪接变体10*、电压门控钙通道α1亚基、电压门控钙通道α亚基Cav1.2、电压门控钙通道α亚基Cav1.3、电压门控钾通道H亚家族成员2、电压门控*通道α亚基Nav1.5、电压依赖性L型钙通道α-1C亚基、电压依赖性L型钙通道α-1D亚基、电压依赖性L型钙通道α-1S亚基、电压门控钙通道α亚基Cav1.1、电压门控钙通道亚基αCav1.2，电压门控钙通道亚基αCav1.3，电压门控钾通道亚基Kv11.1，电压门控*通道亚基αNav1.5，Yama，Yama蛋白，α-1多肽，雄激素受体剪接变体4b，心肌，组成型活性受体，组成型雄烷核受体变体2，组成型雄烷核受体变体3，组成型雄烷核受体变体4，组成型雄烷核受体变体5，细胞色素P450，亚家族IIIA（硝苯地平氧化酶），多肽3，细胞色素P450，亚家族IIIA（硝苯地平氧化酶），多肽4，dJ576K7.1（FK506结合蛋白12雷帕霉素相关蛋白1），多巴胺受体D1，eag同源物，雌激素受体相关受体α黄素蛋白连接单加氧酶、fmd、hERG-1、hERR1、异构体1、异构体2、异构体3、白细胞抗原IB类、主要组织相容性复合体I类、B类、mldy、孤儿核激素受体、进行性家族性肝内胆汁淤积症2型、5-羟色胺1c受体、5-羟色胺2c受体、5-羟色胺5-HT-2受体（曾用名：5-羟色胺5-HT-2A受体）、sj
• 英文别名：1,8-cineole 2-exo-monooxygenase, 1B07_HUMAN, 3dopamine receptor, 5 HT 2B receptor, 5 HT(2B), 5 HT2 receptor, 5 Hydroxytryptamine 2C receptor, 5 hydroxytryptamine (serotonin) receptor 2B, 5 hydroxytryptamine (serotonin) receptor 2B G protein coupled, 5 hydroxytryptamine (serotonin) receptor 6 G protein coupled, 5 hydroxytryptamine 2B receptor, 5 hydroxytryptamine 6 receptor, 5-HT-1C, 5-HT-2, 5-HT-6, 5-HTR2C, 5-ht-1c receptor, 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled, 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled, 5-hydroxytryptamine 2A receptor, 5-hydroxytryptamine receptor 1C, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 6, 5HT2A_HUMAN, 5HT2B_HUMAN, 5HT2C_HUMAN, 5HT2F, 5HT6R_HUMAN, A830040C14Rik, ABC member 16, MDR/TAP subfamily, ABC16, ABCB1, ABCBB_HUMAN, ADA1A_HUMAN, ADA1B_HUMAN, ADA1D_HUMAN, ADRA 1, ADRA1A, ADRA1L1, AI838772, AIS, ALPHA1AAR, AM4 7, ANDR_HUMAN, APOPAIN, AR, AR8, ARO, ARO1, AS, ATP binding cassette sub family B (MDR/TAP) member 11, ATP-binding cassette sub-family B member 11, AW493413, Adra1c, Adra1d, Adrenergic alpha 1A receptor, Adrenergic alpha 1B receptor, Adrenergic alpha 1C receptor, Adrenergic alpha 1D receptor, Adrenergic receptor alpha 1a, Adrenergic receptor alpha 1b, Adrenergic receptor alpha 1c, Adrenergic, alpha 1A , receptor variant 1, Adrenergic, alpha 1A , receptor variant 11, Adrenergic, alpha 1A , receptor variant 3, Adrenergic, alpha 1A , receptor variant 5, Adrenergic, alpha 1A , receptor variant 8, Adrenoceptor alpha 1A, Adrenoceptor alpha 1B, Albendazole monooxygenase, Albendazole sulfoxidase, Alpha 1 adrenergic receptor, Alpha adrenergic receptor 1b, Alpha adrenergic receptor 1d, Alpha-1A adrenergic receptor, Alpha-1A adrenoceptor, Alpha-1A adrenoreceptor, Alpha-1B adrenergic receptor, Alpha-1B adrenoceptor, Alpha-1B adrenoreceptor, Alpha-1C adrenergic receptor, Alpha-1D adrenergic receptor, Alpha-1D adrenoceptor, Alpha-1D adrenoreceptor, Alpha-adrenergic receptor 1a, Alpha-adrenergic receptor 1c, Alpha1BAR, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor, testicular feminization, spinal and bulbar muscular atrophy, Kennedy disease), Apoptotic protease Mch-3, Arachidonic acid epoxygenase, Aromatase, B-4901, B-7 alpha chain, BPHS, mouse, homolog of, BRIC2, Beta-interferon, Bile salt export pump, Bsep, C-C CKR-5, C-C chemokine receptor type 5, C-C motif chemokine receptor 5 A159A, C-mpl ligand, CAC1C_HUMAN, CAC1D_HUMAN, CAC1S_HUMAN, CACH 2, CACH1, CACH3, CACN 2, CACN1, CACN4, CACNA 1D, CACNL1A1, CACNL1A2, CACNL1A3, CAR, CAR BETA, CARA, CASP3_HUMAN, CASP7_HUMAN, CC Chemokine Receptor 5, CC3, CCHL1A1, CCHL1A2, CCHL1A3, CCR5 chemokine (C C motif) receptor 5, CCR5_HUMAN, CD 195, CD195 Antigen, CDCD2, CHEMR13, CKR 5, CMD1E, CMH-1, CMKBR 5, CMPD2, CP19A_HUMAN, CP2J2_HUMAN, CP33, CP34, CP3A4_HUMAN, CPJ2, CPP-32, CPP32B, CPV1, CYAR, CYP19, CYP3, CYP3A, CYP3A3, CYP3A4, CYPIIIA3, CYPIIIA4, CYPIIJ2, CYPXIX, CaV1.2, Cach1b, Calcium channel, Calcium channel L type alpha 1 polypeptide isoform 1 cardiac muscle, Calcium channel L type alpha 1 polypeptide isoform 2, Calcium channel cardic dihydropyridine sensitive alpha 1 subunit, Calcium channel neuroendocrine/brain type alpha 1 subunit, Calcium channel voltage dependent L type alpha 1, Calcium channel voltage dependent L type alpha 1C subunit, Calcium channel voltage dependent L type alpha 1D subunit, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, Calcium channel, L type, alpha 1 polypeptide, isoform 3, skeletal muscle, hypokalemic periodic paralysis, Calcium channel, skeletal muscle dihydropyridine sensitive , alpha 1 subunit, Calcium channel, voltage dependent, L type, alpha 1S subunit, Calcium channel, voltage-dependent, L type, alpha 1S subunit, b, Car 1, Cardiac tetrodotoxin insensitive voltage dependent sodium channel alpha subunit, Casp3a, Caspase 3, apoptosis-related cysteine peptidase, Caspase 3, apoptosis-related cysteine protease, Caspase 3, apoptosis-related cysteine protease a, Caspase 7, Caspase 7 apoptosis related cysteine peptidase, Caspase-3, Caspase-3 subunit p12, Caspase-7 subunit p11, Cav1.1, Cav1.3, Chemokine C C motif receptor 5, Chemokine receptor CCR5, Constitutive activator of retinoid response, Constitutive active response, Constitutive androstane receptor, Cyp19a1, Cysteine protease CPP32, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450 2J2, Cytochrome P450 3A3, Cytochrome P450 3A4, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450 family 2 subfamily J polypeptide 2, Cytochrome P450 family 3 subfamily A polypeptide 4, Cytochrome P450 subfamily IIIA polypeptide 4, Cytochrome P450 subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2, Cytochrome P450 subfamily IIJ polypeptide 2, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), Cytochrome P450-PCN1, D(1A) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor, D1A dopamine receptor, D2 dopamine receptor, D2DR, D2R, DA transporter, DADR, DAT, DAT 1, DHPR alpha 1, DHPR alpha 1 subunit, DHTR, DNA replication inhibitor, DRD 1A, DRD1_HUMAN, DRD2_HUMAN, DRD3_HUMAN, Dihydro testosterone receptor, Dihydropyridine receptor, Dihydropyridine sensitive L type calcium channel alpha 1 subunit, Dihydrotestosterone receptor (DHTR), Dopamine D1 receptor, Dopamine D2 receptor, Dopamine D3 receptor, Dopamine receptor D2, Dopamine receptor D3, Dopamine transporter, Dopamine transporter 1, EC 3.4.22.56, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ESRL 1, ESRR A, ETM1, Eag-related protein 1, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen synthase, Estrogen synthetase, Estrogen-related receptor alpha, Estrra, Ether a go go related potassium channel protein, Ether-a-go-go-related gene potassium channel 1, Ether-a-go-go-related protein 1, FET1, FK506 binding protein 12 rapamycin associated protein 1, FK506 binding protein 12 rapamycin associated protein 2, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP rapamycin associated protein, FKBP12-rapamycin complex-associated protein, FKBP12-rapamycin complex-associated protein 1, FLJ11090, FLJ44809, FLJ78003, FRAP, FRAP1, FRAP2, Fibroblast interferon, G protein coupled receptor, GEMI_HUMAN, GMNN, Geminin, Geminin DNA replication inhibitor, Glucocorticoid inducible P450, H-ERG, H1 R, HB 1, HB2, HBBD, HC class I antigen SHCHA, HH1, HH1R, HIV-1 fusion coreceptor, HLA class I histocompatibility antigen, HLA class I histocompatibility antigen, B alpha chain, HLA-B histocompatibility type, HLP, HOKPP, HRH1_HUMAN, HTR 2, HTR 2A, HTR 6, HTR2, formerly, HTR2C, HUMARA, HYSP1, HisH1, Histamine H(1) receptor, Histamine H1 receptor, Histamine receptor H1, Histamine receptor subclass H1, Htr 2b, Htr1c, HypoPP, ICCD, ICE-LAP3, ICE-like apoptotic protease 3, ICE3, IDDM22, IFB, IFF, IFN-beta, IFNB 1, IFNB_HUMAN, IVF, Interferon beta, Interferon beta 1 fibroblast, Interferon beta precursor, KCNH2_HUMAN, KD, Kennedy disease (KD), Kv11.1, L type, LICE, LICE2, LQT 2, LQT3, LQT8, MB67, MCH3, MGC104252, MGC104309, MGC11*2, MGC126680, MGC163194, MGC96956, MGC97144, MGDF, MHC Class I HLA heavy chain, MHC HLA-B cell surface glycoprotein, MHC HLA-B transmembrane glycoprotein, MHC class 1 antigen, MHC class I antigen HLA-B alpha chain, MHC class I antigen HLA-B heavy chain, MHC class I molecule, MHC class I-antigen B*7, MHS5, MIP-1 alpha receptor, MKCSF, MPL ligand, MPLLG, MTOR_HUMAN, Malignant hyperthermia susceptibility 5, Mammalian target of rapamycin, Mechanistic target of rapamycin, Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, Megakaryocyte stimulating factor, Microsomal monooxygenase, Myeloproliferative leukemia virus oncogene ligand, NF 25, NK-2 receptor, NK2R_HUMAN, NKNAR, NP75 protein, NR1I3_HUMAN, NR3B1, NR3C4, Neurokinin 2 receptor, Neurokinin A receptor, Neurotransmitter transporter, Nifedipine oxidase, Norepinephrine transporter, Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), OTTHUMP00000001983, OTTHUMP00000010550, OTTHUMP00000039393, OTTHUMP00000162543, OTTHUMP00000165052, OTTHUMP00000165053, OTTHUMP00000165054, OTTHUMP00000198350, Orphan nuclear receptor MB67, Orphan nuclear receptor NR1I3, P 450AROM, P450 III steroid inducible, P450 PCN1, P450, family III, P450C3, PARP cleavage protease, PASNA, PFHB1, PFIC 2, PGY4, PKDYS, Potassium channel HERG, Potassium voltage gated channel subfamily H (eag related) member 2, Potassium voltage-gated channel subfamily H member 2, Prepro thrombopoietin, Procaspase3, Protein Yama, Quinine 3-monooxygenase, RAFT1, RAPT1, ROB1, RP24-311F12.2, RP3 369A17.3, Rapamycin and FKBP12 target 1, Rapamycin associated protein FRAP2, Rapamycin target protein, Rapamycin target protein 1, SANDD, SBMA, SC6A2_HUMAN, SC6A3_HUMAN, SCA-1, SCAN1, SCN5A_HUMAN, SEROTONIN 5HT2B RECEPTOR, SKR, SLC6A3, SLC6A5, SMAX1, SPDA1, SQT1, SREBP cleavage activity 1, SSS1, Scn5a (gene name), Serine/threonine-protein kinase mTOR, Serotonin 5-HT-2C receptor, Serotonin receptor 2A, Serotonin receptor 2B, Serotonin receptor 2C, Serotonin receptor 6, Seven transmembrane helix receptor, Sister of P glycoprotein, Slc6a2, Sodium channel protein cardiac muscle alpha subunit, Sodium channel protein cardiac muscle subunit alpha, Sodium channel protein type 5 subunit alpha, Sodium channel protein type V alpha subunit, Sodium channel protein type V subunit alpha, Sodium-dependent dopamine transporter, Sodium-dependent noradrenaline transporter, Solute carrier family 6 (neurotransmitter transporter dopamine), member 3, Solute carrier family 6 (neurotransmitter transporter norepinephrine) member 5, Solute carrier family 6 (neurotransmitter transporter), member 3, Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, Solute carrier family 6 member 2, Solute carrier family 6 member 3, Solute carrier family 6 member 5, Spgp, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid hormone receptor ERR1, Stomach fundus serotonin receptor, Substance-K receptor, TAC 2R, TAC R2, TACR 2, TACR2, TFM, THCYT1, THPO, TPO_HUMAN, TS, TTPP1, TYDP, TYDP1_HUMAN, Tachykinin receptor 2, Tachykinin receptor 2 (substance K receptor, neurokinin 2 receptor), Taurochenodeoxycholate 6-alpha-hydroxylase, Testicular Feminization (TFM), Thrombopoietin, Thrombopoietin nirs variant 1, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, VF1, Variable number tandem repeat (VNTR), Voltage dependent L type calcium channel alpha 1C subunit, Voltage gated L type calcium channel Cav1.2 alpha 1 subunit, splice variant 10*, Voltage gated calcium channel alpha 1 subunit, Voltage gated calcium channel alpha subunit Cav1.2, Voltage gated calcium channel alpha subunit Cav1.3, Voltage gated potassium channel, subfamily H, member 2, Voltage gated sodium channel alpha subunit Nav1.5, Voltage-dependent L-type calcium channel subunit alpha-1C, Voltage-dependent L-type calcium channel subunit alpha-1D, Voltage-dependent L-type calcium channel subunit alpha-1S, Voltage-gated calcium channel subunit alpha Cav1.1, Voltage-gated calcium channel subunit alpha Cav1.2, Voltage-gated calcium channel subunit alpha Cav1.3, Voltage-gated potassium channel subunit Kv11.1, Voltage-gated sodium channel subunit alpha Nav1.5, Yama, Yama protein, alpha-1 polypeptide, androgen receptor splice variant 4b, cardiac muscle, constitutive active receptor, constitutive androstane nuclear receptor variant 2, constitutive androstane nuclear receptor variant 3, constitutive androstane nuclear receptor variant 4, constitutive androstane nuclear receptor variant 5, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3, cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4, dJ576K7.1 (FK506 binding protein 12 rapamycin associated protein 1), dopamine receptor D1, eag homolog, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, fmd, hERG-1, hERR1, isoform 1, isoform 2, isoform 3, leukocyte antigen class I-B, major histocompatibility complex, class I, B, mldy, orphan nuclear hormone receptor, progressive familial intrahepatic cholestasis 2, serotonin 1c receptor, serotonin 2c receptor, serotonin 5-HT-2 receptor, formerly, serotonin 5-HT-2A receptor, sj
• 详细参数：CAS号：50679-08-8纯度：>98%形态：固体参见储存信息分子量：471.7 Da分子式：C32H41NO2 PubChem编号：5405 Nature Synthetic溶解性：溶于DMSO，浓度可达100 mM生化名称：特非那定生物学描述：钾离子通道阻滞剂（Kv11.1）。阻断ATP敏感性钾离子通道（IC50 = 1.2μM）。H1受体拮抗剂。规范SMILE图像CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O InChI InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3 InChIKey GUGOEEXESWIERI-UHFFFAOYSA-N IUPAC名称1-(4-叔丁基苯基)-4-[4-[羟基(二苯基)甲基]*-1-基]丁-1-醇浓度范围
• 成分和储存条件：运输条件：常温-可加冰运输。适宜短期储存条件：+4°C。适宜长期储存条件：+4°C。储存信息：本产品可储存长达12个月。需要更多关于溶解度、使用方法和操作方面的建议？请访问我们的产品支持页面了解更多详情。建议尽可能在当天配制和使用溶液。但是，如果您需要提前配制储备液，我们建议您将溶液分装在密封小瓶中，并储存在-20°C。通常情况下，这些溶液可保存长达一个月。使用前，在打开小瓶之前，我们建议您将产品在室温下平衡至少1小时。更多信息，请参阅安全数据表(SDS)。
• 重组蛋白序列概况：
• 重组蛋白真实序列：
• 靶点概况：

说明：所有内容为机器翻译，仅供参考，产品具体信息以Abcam厂家说明为准。